Articles by George Koroneos, Online Content & News Editor - Pharmaceutical Executive

ADVERTISEMENT

Articles by George Koroneos, Online Content & News Editor

Bayer to Run Corrective Ad for Birth-Control Pill

Feb 18, 2009

FDA reprimanded Bayer for running misleading advertising touting unproven benefits of the contraceptive Yaz. Now the drug company will shell out $20 million for new ads setting the record straight.

Sanofi-Aventis and AZ Launch YouTube Sites

Feb 18, 2009

Two pharma companies dabble in online video in two different but effective ways. Sanofi-aventis attempts to reach patients through educational videos, while AZ calls for consumers to upload their own testimonials.

King Pharma Purges 22 Percent of its Workforce

Feb 4, 2009

Facing patent expiry for one of its top drugs and an overabundance of sales staff due to recent acquisitions, King announced that it would eliminate 760 jobs.

Chantix Bounced From McCann to McGarry Bowen

Feb 4, 2009

Pfizer switched agencies for its popular smoking cessation drug Chantix. While the company is tight lipped about the campaign's new direction, it looks like this may be the end of the tortoise and hare. Does this signal an end to the use of critters in pharma ads?

Publicis Aligns in Messaging Divisions

Feb 4, 2009

Pharma companies are trimming their bloated sales forces by the hundreds. Eyeballing a golden opportunity, Publicis has aligned its independent communications and sales shops under one umbrella, giving pharma a one-stop-shop for filling in sales gaps. Pharm Exec talks to Publicis? Betsy Lane to learn more.

BMS Tops List of Patent Approvals

Jan 28, 2009

Big name patent expirations may be looming, but that's not stopping pharma companies from filing - and getting approved for - dozens of new patents. Pharm Exec looks at which companies are getting the most approvals, and how 2008 compared to previous years.

Two Become One: Pfizer Acquires Wyeth

Jan 28, 2009

Pfizer hit hard with the surprise purchase of Wyeth. But will the pharma giant strike out in the long run? Analysts ponder the long and short-term ramifications of this monster acquisition.

Social Network Use Spikes Among Docs

Jan 21, 2009

A new study suggests the medical professionals are more active on social networking sites than ever before. With the rise of doctor-specific Web 2.0 outlets, pharma has a new tool for reaching elusive physicians. The best part: Doctors don?t seem to mind.

Analysts Speculate on Pfizer Cuts

Jan 21, 2009

Rumors is that Pfizer will lay off a third of its sales force. It's still up in the air, but analysts predict that the truth may not be far from the speculation.

ADVERTISEMENT

Click here